Results 101 to 110 of about 65,278 (248)
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Background Sublingual buprenorphine, approved for treatment of opioid use disorder since 2002, is most commonly available in co-formulation with naloxone.
Hannan M. Braun +2 more
doaj +1 more source
Promoting Awareness of Resources Available at Syringe Exchanges in Windsor County, VT [PDF]
Heroin addiction is a problem nationwide, and is especially prevalent in the state of Vermont. Individuals who inject heroin are at risk of infection with HIV or hepatitis C, and of death by heroin overdose.
Worswick, Erica
core +1 more source
Local Responses to Limits on U.S. Public Health Authority During the COVID‐19 Emergency
ABSTRACT Public health has become politicized in the U.S. Though research shows that limiting public health authority during emergency response puts community wellbeing and health outcomes at risk, during the COVID‐19 emergency (2020–2021), some U.S. state policymakers limited the disease‐preventing actions local public health agencies could take. This
Genevive R. Meredith +6 more
wiley +1 more source
The Heroin Crisis Act: What You Need to Know about the New Law [PDF]
The Heroin Crisis Act aims to address the heroin epidemic in Illinois through improved access to treatment and expanded overdose prevention activities.
Daniel Rabbitt
core
Examining buprenorphine compared to methadone for likelihood of overdose during pregnancy, 2014–2021
Abstract Objective To examine the likelihood of experiencing an overdose among women receiving any buprenorphine (with or without naloxone) compared to women receiving methadone during pregnancy. Methods Data from the MATernaL and Infant clinical NetworK (MAT‐LINK), a longitudinal surveillance system of pregnant woman–child dyads using electronic ...
Amy Board +20 more
wiley +1 more source
A Background of the Opioid Epidemic and Its Relationship to the Medicaid Expansion [PDF]
Despite the recent increase in public awareness of the opioid epidemic, the background of this epidemic is still disappointingly unknown to the public.
Jang, Er Yearn
core +2 more sources
Abstract Background and aims Harm reduction interventions aim to reduce negative consequences of drug use. We aimed to estimate the cost, health impact and economic benefits of current, expanded and new harm reduction interventions for people who use drugs in the Australian Capital Territory.
Anna L. Bowring +8 more
wiley +1 more source
Christa R Lewis,1,2 Hoa T Vo,1 Marc Fishman1,3 1Maryland Treatment Centers, Baltimore, MD, USA; 2Department of Psychology, Towson University, Towson, MD, USA; 3Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, USA Abstract ...
Lewis CR, Vo HT, Fishman M
doaj
Considering the Potential Benefits of Over-the-Counter Naloxone
Kirk E Evoy,1 Lucas G Hill,2 Corey S Davis3 1University Health, Department of Pharmacy, The University of Texas at Austin College of Pharmacy, San Antonio, TX, USA; 2Pharmacy Practice, The University of Texas at Austin College of Pharmacy, Austin, TX ...
Evoy KE, Hill LG, Davis CS
doaj
Comprehensive User Engagement Sites (CUES) in Philadelphia: A Constructive Proposal [PDF]
This paper is a study about Philadelphia’s comprehensive user engagement sites (CUESs) as the authors address and examine issues related to the upcoming implementation of a CUES while seeking solutions for its disputed questions and plans. Beginning with
Clark, Peter +12 more
core

